Westlake Longevity Cohort

Study acronym: We-Longevity
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years later Nov 14, 2025 → Nov 14, 2028
See other at-risk trials from Westlake University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Nov 14, 2025 to Nov 14, 2028 Show 4 more changesShow less
    • Enrollment increased: 1500 → 2800 participants
    • Secondary endpoints revised (3)
    • Study site revised
    • Eligibility criteria expanded, about 5 words
  2. Primary endpoints revised (2)v5 Show 6 more changesShow less
    • Enrollment target: 1200 to 1500
    • Eligibility criteria shortened, about 11 words
    • Secondary endpoints revised (3)
    • Study site revised
    • Collaborators shortened, about 8 words
    • Study description expanded, about 3 words
  3. Primary endpoints: 5 to 2
    • Secondary endpoints: 5 to 3
    • Site contact updated
    • Study description shortened, about 2 words
    v4
  4. Enrollment target: 2400 to 1200
    • Primary completion date: Nov 14, 2024 to Nov 14, 2025
    • Study description shortened, about 18 words
    v3
  5. Enrollment target: 800 to 2400
    • Eligibility criteria revised
    • Secondary endpoints revised (5)
    • Study description expanded, about 15 words
    v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Zhejiang Province, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.
Trial Details
NCT Number NCT05256251
Lead Sponsor Westlake University
Conditions
(from sponsor)		 Aging
Enrollment 2,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov